Russias Gamaleya Research Center for Epidemiology and Microbiology intends to launch the preclinical trials of its coronavirus vaccine based on the messenger ribonucleic acid (mRNA) technology by the end of 2022, the centers deputy director, Denis Logunov, said on Thursday.On Wednesday, he said th ..